{"data":[{"accessionNo":"0001274173-26-000206","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS INC","ticker":"DYN","cusip":"26818M108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"JANUS HENDERSON GROUP Ltd.","reportingCik":null,"personType":"HC","sharesOwned":11997738,"percentOfClass":7.3,"filedAt":"2026-08-13"},{"accessionNo":"0001708269-26-000007","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":"26818M108","securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2026-06-30","reportingPerson":"Atlas Venture Fund XI, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4476487,"percentOfClass":2.4,"filedAt":"2026-08-13"},{"accessionNo":"0001708269-26-000007","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":"26818M108","securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2026-06-30","reportingPerson":"Atlas Venture Associates XI, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4479449,"percentOfClass":2.4,"filedAt":"2026-08-13"},{"accessionNo":"0001708269-26-000007","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":"26818M108","securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2026-06-30","reportingPerson":"Atlas Venture Associates XI, LLC","reportingCik":null,"personType":"OO","sharesOwned":4479449,"percentOfClass":2.4,"filedAt":"2026-08-13"},{"accessionNo":"0001708269-26-000007","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":"26818M108","securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2026-06-30","reportingPerson":"Atlas Venture Associates Opportunity II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1344719,"percentOfClass":0.7,"filedAt":"2026-08-13"},{"accessionNo":"0001708269-26-000007","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":"26818M108","securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2026-06-30","reportingPerson":"Atlas Venture Opportunity Fund II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1344719,"percentOfClass":0.7,"filedAt":"2026-08-13"},{"accessionNo":"0001708269-26-000007","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":"26818M108","securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2026-06-30","reportingPerson":"Atlas Venture Associates Opportunity II, LLC","reportingCik":null,"personType":"OO","sharesOwned":1344719,"percentOfClass":0.7,"filedAt":"2026-08-13"},{"accessionNo":"0001708269-26-000007","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":"26818M108","securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2026-06-30","reportingPerson":"Atlas Venture Opportunity Fund I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":975931,"percentOfClass":0.5,"filedAt":"2026-08-13"},{"accessionNo":"0001708269-26-000007","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":"26818M108","securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2026-06-30","reportingPerson":"Atlas Venture Associates Opportunity I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":975931,"percentOfClass":0.5,"filedAt":"2026-08-13"},{"accessionNo":"0001708269-26-000007","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":"26818M108","securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2026-06-30","reportingPerson":"Atlas Venture Associates Opportunity I, LLC","reportingCik":null,"personType":"OO","sharesOwned":975931,"percentOfClass":0.5,"filedAt":"2026-08-13"},{"accessionNo":"0000315066-26-001991","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS INC","ticker":"DYN","cusip":"26818M108","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":11206999.89,"percentOfClass":6.8,"filedAt":"2026-08-06"},{"accessionNo":"0000315066-26-001991","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS INC","ticker":"DYN","cusip":"26818M108","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":11206999.89,"percentOfClass":6.8,"filedAt":"2026-08-06"},{"accessionNo":"0002012383-26-002476","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001818794","issuerName":"Dyne Therapeutics, Inc.","ticker":"DYN","cusip":"26818M108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":11489504,"percentOfClass":7,"filedAt":"2026-07-28"},{"accessionNo":"0001897612-26-000494","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS INC","ticker":"DYN","cusip":"26818M108","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":30785801,"percentOfClass":18.7,"filedAt":"2026-05-15"},{"accessionNo":"0001274173-26-000136","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS INC","ticker":"DYN","cusip":"26818M108","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":13647376,"percentOfClass":8.3,"filedAt":"2026-05-15"},{"accessionNo":"0000315066-26-001175","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS INC","ticker":"DYN","cusip":"26818M108","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":8908979.89,"percentOfClass":5.4,"filedAt":"2026-05-06"},{"accessionNo":"0000315066-26-001175","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS INC","ticker":"DYN","cusip":"26818M108","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":8908979.89,"percentOfClass":5.4,"filedAt":"2026-05-06"},{"accessionNo":"0000102909-26-001148","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001818794","issuerName":"Dyne Therapeutics Inc","ticker":"DYN","cusip":"26818M108","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26"},{"accessionNo":"0001897612-26-000307","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS INC","ticker":"DYN","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2026-02-28","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":26578437,"percentOfClass":16.2,"filedAt":"2026-03-06"},{"accessionNo":"0001274173-26-000088","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS INC","ticker":"DYN","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":13887722,"percentOfClass":8.5,"filedAt":"2026-02-17"},{"accessionNo":"0001897612-26-000009","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS INC","ticker":"DYN","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":17540089,"percentOfClass":10.7,"filedAt":"2026-01-08"},{"accessionNo":"0001274173-25-000289","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS INC","ticker":"DYN","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":14745505,"percentOfClass":10.4,"filedAt":"2025-11-14"},{"accessionNo":"0001231919-25-000487","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14"},{"accessionNo":"0001231919-25-000487","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14"},{"accessionNo":"0001231919-25-000487","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14"},{"accessionNo":"0001231919-25-000487","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-30","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-14"},{"accessionNo":"0001708269-25-000006","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":null,"securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2025-09-30","reportingPerson":"Atlas Venture Fund XI, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5697508,"percentOfClass":4,"filedAt":"2025-11-13"},{"accessionNo":"0001708269-25-000006","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":null,"securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2025-09-30","reportingPerson":"Atlas Venture Associates XI, LLC","reportingCik":null,"personType":"OO","sharesOwned":5713470,"percentOfClass":4,"filedAt":"2025-11-13"},{"accessionNo":"0001708269-25-000006","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":null,"securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2025-09-30","reportingPerson":"Atlas Venture Associates XI, L.P.","reportingCik":null,"personType":"PN","sharesOwned":5713470,"percentOfClass":4,"filedAt":"2025-11-13"},{"accessionNo":"0001708269-25-000006","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":null,"securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2025-09-30","reportingPerson":"Atlas Venture Associates Opportunity II, LP","reportingCik":null,"personType":"PN","sharesOwned":1958427,"percentOfClass":1.4,"filedAt":"2025-11-13"},{"accessionNo":"0001708269-25-000006","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":null,"securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2025-09-30","reportingPerson":"Atlas Venture Opportunity Fund II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1958427,"percentOfClass":1.4,"filedAt":"2025-11-13"},{"accessionNo":"0001708269-25-000006","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":null,"securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2025-09-30","reportingPerson":"Atlas Venture Associates Opportunity II, LLC","reportingCik":null,"personType":"OO","sharesOwned":1958427,"percentOfClass":1.4,"filedAt":"2025-11-13"},{"accessionNo":"0001708269-25-000006","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":null,"securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2025-09-30","reportingPerson":"Atlas Venture Associates Opportunity I, LLC","reportingCik":null,"personType":"OO","sharesOwned":1458568,"percentOfClass":1,"filedAt":"2025-11-13"},{"accessionNo":"0001708269-25-000006","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":null,"securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2025-09-30","reportingPerson":"Atlas Venture Associates Opportunity I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1458568,"percentOfClass":1,"filedAt":"2025-11-13"},{"accessionNo":"0001708269-25-000006","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001818794","issuerName":"DYNE THERAPEUTICS, INC.","ticker":"DYN","cusip":null,"securityClass":"COMMON STOCK, $0.0001 PAR VALUE","eventDate":"2025-09-30","reportingPerson":"Atlas Venture Opportunity Fund I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1458568,"percentOfClass":1,"filedAt":"2025-11-13"}],"updatedAt":"2026-09-14T13:44:28.381Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data"}